May 28, 2026 08:50AM
May 28, 2026 08:50AM
May 8, 2026 04:05PM
Apr 14, 2026 08:45AM
Apr 2, 2026 08:46AM
Apr 2, 2026 08:45AM
Mar 27, 2026 04:05PM Entera Bio Announces Full Year 2025 Financial Results and Provides Business Updates
Mar 4, 2026 08:30AM
Mar 4, 2026 08:30AM
Feb 11, 2026 09:03AM
Feb 11, 2026 09:00AM
Feb 9, 2026 08:50AM
Feb 9, 2026 08:50AM
Feb 4, 2026 08:02AM OPKO Health and Entera Bio expand partnership for oral PTH tablet
Feb 4, 2026 08:00AM
Jan 21, 2026 08:31AM
Jan 21, 2026 08:30AM
Jan 21, 2026 08:30AM
Dec 24, 2025 06:44AM
Dec 23, 2025 08:30AM
Dec 22, 2025 08:32AM Entera Bio reports preclinical data for once-daily hypoparathyroidism tablet
Dec 22, 2025 08:30AM
Nov 18, 2025 08:00AM
Nov 14, 2025 04:05PM
Oct 23, 2025 08:50AM
Oct 23, 2025 08:50AM
Oct 16, 2025 08:45AM
Oct 16, 2025 08:45AM Entera Bio to Present New Clinical Data from Phase 2 Trial of EB613 at the 2025 North American Menopause Society (NAMS) Annual Meeting
Sep 15, 2025 09:01AM
Sep 15, 2025 09:00AM
Sep 8, 2025 08:32AM
Sep 8, 2025 08:30AM
Aug 28, 2025 08:05AM
Aug 28, 2025 08:00AM
Aug 8, 2025 04:05PM Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates
Jul 28, 2025 07:30AM
Jul 28, 2025 07:30AM
Jul 8, 2025 08:03AM
Jul 8, 2025 08:00AM
Jun 26, 2025 08:00AM
Jun 25, 2025 08:05AM
Jun 25, 2025 08:00AM OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting
May 9, 2025 04:05PM
Apr 15, 2025 08:32AM
Apr 15, 2025 08:30AM
Mar 28, 2025 04:05PM
Mar 17, 2025 08:01AM
Mar 17, 2025 08:00AM
Feb 24, 2025 08:30AM Entera Bio to Participate in Upcoming Events
Feb 19, 2025 08:00AM

322,256 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All